SightfileU.S. market data from official filings

Companies › XLO

XILIO THERAPEUTICS INC (XLO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001840233 · EDGAR filings · Updated 2026-06-12

XILIO THERAPEUTICS INC (XLO) has reported institutional ownership of 34.1%, with 23 institutional managers holding positions valued at $16.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
34.1%
Institutional managers
23
Reported 13F value
$16.6M
Insider activity
10 trans.
$111.3K net buying
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, XILIO THERAPEUTICS INC has 23 institutional holders and institutional ownership of 34.1%.

Insider activity

Insiders reported 10 transactions (4 buys, 2 sells) across 5 reporting insiders, with a net reported value of $111.3K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-11-13 (recurring since 2023-08-14) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-10-03 (recurring since 2024-01-19) — source filing. The authoritative details are those stated in the filing itself.

Related companies

POLARYX THERAPEUTICS INC (PLYX) · TUHURA BIOSCIENCES INC (HURA) · Tela Bio Inc (TELA) · TALPHERA INC (TLPH) · Cognition Therapeutics Inc (CGTX) · NEPHROS INC (NEPH)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-12.